Cart
sales@molnova.com
NS 1619
CAS No. 153587-01-0
NS 1619 ( NS1619; NS-1619; NS 1619. )
Catalog No. M12168 CAS No. 153587-01-0
NS1619 have been reported to have cardio-protective effects after ischemic-reperfusion injury.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 88 | In Stock |
|
| 25MG | 161 | In Stock |
|
| 50MG | 239 | In Stock |
|
| 100MG | 356 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNS 1619
-
NoteResearch use only, not for human use.
-
Brief DescriptionNS1619 have been reported to have cardio-protective effects after ischemic-reperfusion injury.
-
DescriptionNS1619 have been reported to have cardio-protective effects after ischemic-reperfusion injury.
-
SynonymsNS1619; NS-1619; NS 1619.
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number153587-01-0
-
Formula Weight362.23
-
Molecular FormulaC15H8F6N2O2
-
Purity>98%(HPLC)
-
SolubilityDMSO: > 10 mM
-
SMILESO=C1NC2=CC(C(F)(F)F)=CC=C2N1C3=CC(C(F)(F)F)=CC=C3O
-
Chemical Name1-(2-hydroxy-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kurra V, et al. BMC Nephrol. 2015 Mar 27;16:35.
molnova catalog
related products
-
Gut restricted-7
Gut restricted-7 (GR-7) is a covalent and orally active pan-bile salt hydrolase (BSH) inhibitor. It decreases gut bacterial BSHs and decreases deconjugated bile acid levels in the feces of mice.
-
Lei-Dab 7
High affinity, selective KCa2.2 (SK2) channel blocker (Kd = 3.8 nM). Exhibits >200-fold selectivity for KCa2.2 over KCa2.1, KCa2.3, KCa3.1, IK, Kv and Kir2.1. Increases theta-burst responses and increases LTP in rat hippocampal slices in vitro. Convulsive in vivo.
-
JNJ 303
JNJ 303 is a potent blocker of IKs (IC50 : 64 nM).
